Introduction
The admixture between different ointments have now frequently used in the clinical field to improve skin therapy by many dermatological doctors. Main reasons to prepare the admixture are to improve compliance, reduce adverse effect of drug, and increase in drug efficacy. Fig. 1 . The skin was treated by each ointment for 24 h and the treated sample was refrigerated promptly to avoid the dispersion of corticosteroid molecules during storage. The skin sample was thawed and the cross section was cut out just before the EPMA analysis.
Results and Discussion 1. Homogeneity and stability of admixed ointments Homogeneity of the admixed ointments was examined as fundamental information. The analytical content of corticosteroid in the admixed ointment is shown in Table 1 . The analytical content of each corticosteroid in the admixture was almost 50% to that of the primary ointment as expected from the dilution ratio of 1.0 : 1.0. The standard deviation of each active ingredient was also satisfactory suggesting a good homogeneity.
Long term stability of the admixture was examined. The analytical content of alclometasone and difluprednate in the stored admixtures is shown in Table 2 . No significant decrease was observed in the content of each corticosteroid within the limit of experimental error either in the admixture with white petrolatum or with urea ointment. Appearance change was also examined and the result is shown in Table  3 . No apparent change such as color was observed in the admixtures with white petrolatum irrespective of the storage period until 3 months either in Almeta® or Myser® ointments. In the admixtures with urea ointment, on the other hand, a fluid liquid appeared on the surface one month after the mixing. Similar phenomenon was reported on 0/W type ointments like Urepearl® by many authors3'5'17'18). The hygroscopic property of urea ointment must result in the appearance of liquid phase and reduced the stability of the admixtures with urea ointment. Any change was observed on the surface of the admixtures with white petrolatum.
Release property from ointment
The direct drug release property from the donor ointment phase into the receptor solution phase was examined to know the diffusion rate of corticosteroid molecules in the ointments. Drug release rate from the donor phase depends on many factors such as solubility to the base ointment, solubility to water, viscosity and molecular weight, crystal form, etc. The solubility of alclometasone and difluprednate to the solution phase were 18.3p g/mL and 112 g/mL, respectively. The solubility was large enough to avoid saturation in this study. The released amount of each corticosteroid is plotted vs. square root of time as shown in Fig. 2 according to the diffusion equation19). The initial release rate was estimated from the initial slope of each curve. The initial lag time occurred in the release curves because it was required certain time to reach steady concentration gradient within narrow channels of membrane. The situation is similar to the delay in passing through the pig skin'''. The starting point to calculate the initial slope was then assumed to be 9 h and 4 h after the starting time of release study for alclometasone and difluprednate, respectively. The initial slope was estimated from the linear approximation of the data points from 0 h to 24 h including the hypothetical stating point and release rate was calculated. The results are shown in Table 4 . In the case of Almeta® and its admixtures, the relative release rates of alclometasone in Almeta®, admixture with white petrolatum, and admixture with urea ointment were 1.0 : 0.14 : 0.30. In the case of Myser® and its admixtures, the relative release rates of difluprednate in Myser®, admixture with white petrolatum, and admixture with urea ointment were 1.0 : 0.22 : 0.26. The release rate of admixed ointments was smaller than a half of the primary corticosteroid ointments in spite that the dilution ratio was 0.5.
The admixture with urea ointment showed larger release rate than that of the admixture with white petrolatum in Almeta®. The difference in the release rate must be ascribed to the different diffusion coefficient that depends on the viscosity of the donor phase. White petrolatum was viscous fat and oil type ointment. On the other hand, urea ointment used was somewhat fluidal O/W type ointment. In fact, it was reported that admixtures with urea ointment resulted in larger release rate than those with white petrolatum in the case of emulsion-based ointment16).
Penetration property of corticosteroids into YMP skin
Following the drug release study, the penetration property of corticosteroid into the real skin was examined using a model YMP skin. Prior to examine the amount of corticosteroids penetrated, metabolism of alclometasone and Overall penetration process of a drug into the skin occurs in three steps. These are (i) diffusion in the ointment phase to the interface, (ii) transfer across the interface and adsorption onto the skin surface and (iii) penetration into the skin, mainly stratum comeum.
The quantitative comparison of the amount of corticosteroid in the release rate, Table 4 , with the penetration amount, Table 5 , was impossible because the former was examined through a porous filter with small effective area, while the latter used whole area of the interface. Considering such difference, release rate and penetration amount was compared.
In the case of primary Almeta® ointment, the amount of alclometasone penetrated was 8.25p g and the amount of alclo- ointment and rat skin and reduced the percutaneous absorption21).
Distribution of corticosteroid molecules in YMP skin
Distribution of corticosteroid molecules in the YMP skin was examined using EPMA. The distribution of difulprednate that contained fluorine is shown in Fig. 3(a)-3(c) for each admixture of MyserR. The left side of photos is the outer surface of skin and right side corium. Upper two photos are ordinary SEM image and red line in the left photo indicates the average fluorine distribution. The epidermis including stratum corneum is displayed visibly in SEM image. Distributions of difulprednate in primary Myser® ointment, Fig. 3(a) , and white petrolatum admixtures, Fig. 3(b) , were quite different between the stratum comeum and other stratums in epidermis. Difulprednate was found to distribute selectively in the stratum comeum. The result is consistent with the report that drugs with rather large molecular weight remained mostly in the stratum comeum22).
On the other hand, distribdution of difulprednate in the admixture with urea ointment was rather homogeneous comparing with the former two samples, Fig. 3(c) . It was observed obviously that difulprednate did not remain in the stratum corneum and suggested that urea ointment accelerated the diffusion rate through the epidermis and increased the amount of corticosteroid penetrated into YMP skin. The result of EPMA seems consistent well with the result that penetration amount of difulprednate for the admixture with urea ointment was 0.79 to that of primary Myser® ointment and fairly larger than that expected from the mixing ratio of 0.5 as shown in Table 5 . Fig. 3(d) shows the distribution of alclometasone that contain chlorine atom in the YMP skin. Since the sensitivity of the X-ray emission of chlorine was poor and reliability was rather low in comparison with MyserR ointment, qualitative consideration seems probable. Alclometasone seemed to distribute mainly in the stratum corneum either in the AlmetaR or in the admixture with urea ointment. The fact suggested that acceleration effect of urea ointment was small in comparison with MyserR ointment. However, further observation required for the definite discussion because of the poor sensitivity of chlorine emission in EPMA.
Release property and penetration property
Comparing the release rate of each corticosteroid in Table   4 with the penetrated amount of corticosteroids in Table 5 relationship was reported between in vitro drug release from ointments and in vivo percutaneous absorption24). The study was carried out using identical base ointment and only difference was the receptor phase solvents. In the present study, the admixture of different base ointments were examined and found that the difference in base ointments had a poor correlation between the release rate and the amount of penetrated amount. Actually, penetration and permeation are different phenomena. The present study, however, suggested that the peculiarity of admixture ointments should not ascribe not only to the release property and surface property of skin but also physicochemical affinity that related to the base corticosteroid, dilution ointment, and skin property. The retardation on the optimum preparation condition prepared by manufactures should also be noticed. Fundamental and systematic studies on various combinations of primary ointments with dilution ointments are thus required. EPMA study visibly certified such approach. For further development of this study, it is expected for the admixed ointments independently prepared in the hospitals to conduct preliminary clinical tests based on the correct protocol using injured skin, drug metabolism, etc. The accumulation of various data on such admixed ointments is required in a similar manner to the commercially available ointments and the data should be reflected in the therapies.
